Back
Vertex Pharmaceuticals Stock Price Chart
Buy
72
VRTX
Vertex Pharmaceuticals
Last Price:
440.72
Seasonality Move:
7.52%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Vertex Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 421.18 | Buy |
| 20-day SMA: | 407.51 | Buy |
| 50-day SMA: | 408.39 | Buy |
| 200-day SMA: | 387.23 | Buy |
| 8-day EMA: | 422.9 | Buy |
| 20-day EMA: | 413.18 | Buy |
| 50-day EMA: | 410.18 | Buy |
| 200-day EMA: | 389.14 | Buy |
Vertex Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.57 | Buy |
| Relative Strength Index (14 RSI): | 75.68 | Buy |
| Chaikin Money Flow: | 705813 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (392.54 - 418) | Buy |
| Bollinger Bands (100): | (403.36 - 428.9) | Buy |
Vertex Pharmaceuticals Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 437.49 while VRTX 8-day simple moving average is 421.18, which is a Buy signal.
- The stock price of VRTX is 437.49 while Vertex Pharmaceuticals 20-day SMA is 407.51, which makes it a Buy.
- Vertex Pharmaceuticals 50-day simple moving average is 408.39 while VRTX share price is 437.49, making it a Buy technically.
- VRTX stock price is 437.49 and Vertex Pharmaceuticals 200-day simple moving average is 387.23, creating a Buy signal.
VRTX Technical Analysis vs Fundamental Analysis
Buy
72
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a Buy
The current Vertex Pharmaceuticals [VRTX] share price is $437.49. The Score for VRTX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
112.9B
Price in USD:
437.49
Share Volume:
1.06M
Vertex Pharmaceuticals 52-Week Range
52-Week High:
448.40
52-Week Low:
320.01
Buy
72
Vertex Pharmaceuticals (VRTX)
is a Buy
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?
The Vertex Pharmaceuticals stock price is 437.49 USD today. -
Will VRTX stock go up or go down?
Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Vertex Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is not overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 437.49 while VRTX 8-day exponential moving average is 422.90, which is a Buy signal.
- The stock price of VRTX is 437.49 while Vertex Pharmaceuticals 20-day EMA is 413.18, which makes it a Buy.
- Vertex Pharmaceuticals 50-day exponential moving average is 410.18 while VRTX share price is 437.49, making it a Buy technically.
- VRTX stock price is 437.49 and Vertex Pharmaceuticals 200-day simple moving average is 389.14, creating a Buy signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.78 per share, an increase this year of $2.05 per share, and an increase next year of $1.12 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
- VRTX Moving Average Covergence Divergence (MACD) indicator is 6.57, suggesting Vertex Pharmaceuticals is a Buy
- Vertex Pharmaceuticals Relative Strength Index (RSI) is 75.68, which suggest Vertex Pharmaceuticals is overbought
- The Bollinger Bands (25) for Vertex Pharmaceuticals is (392.54 - 418), which suggest Vertex Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Vertex Pharmaceuticals is (403.36 - 428.9), which suggest Vertex Pharmaceuticals is a Buy
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.